Cargando…

Design clues from functional constraints and broadly neutralizing antibodies

Detalles Bibliográficos
Autores principales:	Zhou, Tongqing, Xu, Ling, Dey, Barna, Hessell, Ann J, Majeed, Shahzad, Van Ryk, Donald, Xiang, Shi-Hua, Yang, Xinzhen, Zhang, Mei-Yun, Zwick, Michael B, Arthos, James, Burton, Dennis R, Dimitrov, Dimiter S, Sodroski, Joseph, Wyatt, Richard, Nabel, Gary J, Kwong, Peter D
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1716930/ http://dx.doi.org/10.1186/1742-4690-3-S1-S22

Ejemplares similares

Structural definition of a conserved neutralization epitope on HIV-1 gp120
por: Zhou, Tongqing, et al.
Publicado: (2007)

P04-38. Crystal structure of gp120 in complex with the CD4-binding-site antibody b13 suggests precise targeting is needed for neutralization
por: Zhou, T, et al.
Publicado: (2009)

Advancing HIV Broadly Neutralizing Antibodies: From Discovery to the Clinic
por: Spencer, David A., et al.
Publicado: (2021)

The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires
por: Prabakaran, Ponraj, et al.
Publicado: (2014)

Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
por: Hessell, Ann J., et al.
Publicado: (2009)

Structure-Based Stabilization of HIV-1 gp120 Enhances Humoral Immune Responses to the Induced Co-Receptor Binding Site
por: Dey, Barna, et al.
Publicado: (2009)

Structural and genetic basis for development of broadly neutralizing influenza antibodies
por: Lingwood, Daniel, et al.
Publicado: (2012)

Metabolic Clues: Novel Directives for Broad Treatment Strategies
por: Maiese, Kenneth
Publicado: (2010)

Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
por: Ying, Tianlei, et al.
Publicado: (2015)

A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
por: Walker, Laura M., et al.
Publicado: (2010)

Identification and specificity of broadly neutralizing antibodies against HIV
por: McCoy, Laura E., et al.
Publicado: (2017)

Stringent and complex sequence constraints of an IGHV1–69 broadly neutralizing antibody to influenza HA stem
por: Teo, Qi Wen, et al.
Publicado: (2023)

Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens
por: Xiao, Xiaodong, et al.
Publicado: (2009)

Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies
por: Xiao, Xiaodong, et al.
Publicado: (2009)

Revisiting an IgG Fc Loss-of-Function Experiment: the Role of Complement in HIV Broadly Neutralizing Antibody b12 Activity
por: Goldberg, Benjamin S., et al.
Publicado: (2021)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

sCD4-17b bifunctional protein: Extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates
por: Lagenaur, Laurel A, et al.
Publicado: (2010)

CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques
por: Sarkar, Sanghita, et al.
Publicado: (2021)

Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
por: Zhou, Panpan, et al.
Publicado: (2019)

bNAber: database of broadly neutralizing HIV antibodies
por: Eroshkin, Alexey M., et al.
Publicado: (2014)

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
por: McCoy, Laura E., et al.
Publicado: (2015)

Free Energy Perturbation Calculation of Relative Binding Free Energy between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1
por: Clark, Anthony J., et al.
Publicado: (2017)

Computational Prediction of Broadly Neutralizing HIV-1 Antibody Epitopes from Neutralization Activity Data
por: Ferguson, Andrew L., et al.
Publicado: (2013)

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III
por: Hu, Dan, et al.
Publicado: (2019)

Bispecific Engineered Antibody Domains (Nanoantibodies) That Interact Noncompetitively with an HIV-1 Neutralizing Epitope and FcRn
por: Gong, Rui, et al.
Publicado: (2012)

SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization
por: Mannar, Dhiraj, et al.
Publicado: (2022)

Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
por: Cottrell, Christopher A., et al.
Publicado: (2021)

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections
por: Ying, Tianlei, et al.
Publicado: (2015)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2018)

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
por: Huang, Jinghe, et al.
Publicado: (2012)

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023)

Isolation of a clonal lineage of IgA broadly neutralizing antibodies from a chronically infected Tanzanian subject
por: Moody, M, et al.
Publicado: (2012)

Removal of variable domain N-linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies
por: Chuang, Gwo-Yu, et al.
Publicado: (2020)

Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
por: Prigent, Julie, et al.
Publicado: (2018)

Stapled HIV-1 Peptides Recapitulate Antigenic Structures and Engage Broadly Neutralizing Antibodies
por: Bird, Gregory H., et al.
Publicado: (2014)

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Tackling influenza with broadly neutralizing antibodies
por: Corti, Davide, et al.
Publicado: (2017)

Structural basis for broad coronavirus neutralization
por: Sauer, Maximilian M., et al.
Publicado: (2021)

Broadly Neutralizing Synthetic Cannabinoid Vaccines
por: Lin, Mingliang, et al.
Publicado: (2020)

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
por: Liao, Hua-Xin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9obq4ri880prqd6kf2q7pot8e7